Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Abcellera Biologics Inc
ABCLCurrent price
2.39 USD
-0.05 USD (-2.05%)
Last closed
2.43 USD
Company
www.abcellera.com
ISIN
CA00288U1066
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
754 344 896 USD
Yield for 12 month
-57.01 %
1Y
3Y
5Y
10Y
15Y
ABCL
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada. Address: 2215 Yukon Street, Vancouver, BC, Canada, V5Y 0A1
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.43 USDP/E ratio
–Dividend Yield
–Current Year
+38 025 000 USD
Last Year
+485 424 000 USD
Current Quarter
+7 323 000 USD
Last Quarter
+9 954 000 USD
Current Year
+7 131 000 USD
Last Year
+418 988 000 USD
Current Quarter
-30 714 000 USD
Last Quarter
+3 188 000 USD
Key Figures ABCL
1 year
3 years
5 years
10 years
EBITDA
-214 655 008 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-11.41 %
PEG Ratio
–
Return On Equity TTM
-13.3 %
Wall Street Target Price
15.43 USD
Revenue TTM
33 054 000 USD
Book Value
3.77 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-27.2 %
Dividend Yield
–
Gross Profit TTM
311 109 000 USD
Earnings per share
-0.53 USD
Diluted Eps TTM
-0.53 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
45.9 %
Profit Margin
–
Dividend Analytics ABCL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ABCL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ABCL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
27.4725
Enterprise Value Revenue
4.6762
Price Sales TTM
22.8216
Enterprise Value EBITDA
5.3008
Price Book MRQ
0.6777
Financials ABCL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ABCL
For 52 weeks
2.4 USD
6.06 USD
50 Day MA
2.85 USD
Shares Short Prior Month
17 415 579
200 Day MA
4.17 USD
Short Ratio
14.07
Shares Short
18 168 144
Short Percent
8.01 %
BeatStart